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The ‘Cancer Home-Life Intervention’: A 
randomised controlled trial evaluating the 
efficacy of an occupational therapy–based 
intervention in people with advanced 
cancer
Marc Sampedro Pilegaard1,2 , Karen la Cour1,2,  
Lisa Gregersen Oestergaard3,4, Anna Thit Johnsen5,6,  
Line Lindahl-Jacobsen7, Inger Højris8 and Åse Brandt1,2,9
Abstract
Background: People with advanced cancer face difficulties with their everyday activities at home that may reduce their health-related 
quality of life. To address these difficulties, we developed the ‘Cancer Home-Life Intervention’.
Aim: To evaluate the efficacy of the ‘Cancer Home Life-Intervention’ compared with usual care with regard to patients’ performance 
of, and participation in, everyday activities, and their health-related quality of life.
Design and intervention: A randomised controlled trial (ClinicalTrials.gov NCT02356627). The ‘Cancer Home-Life Intervention’ 
is a brief, tailored, occupational therapy–based and adaptive programme for people with advanced cancer targeting the performance 
of their prioritised everyday activities.
Setting/participants: Home-living adults diagnosed with advanced cancer experiencing functional limitations were recruited from 
two Danish hospitals. They were assessed at baseline, and at 6 and 12 weeks of follow-up. The primary outcome was activities of 
daily living motor ability. Secondary outcomes were activities of daily living process ability, difficulty performing prioritised everyday 
activities, participation restrictions and health-related quality of life.
Results: A total of 242 participants were randomised either to the intervention group (n = 121) or the control group (n = 121). 
No effect was found on the primary outcome (between-group mean change: –0.04 logits (95% confidence interval: –0.23 to 0.15); 
p = 0.69). Nor was any effect on the secondary outcomes observed.
Conclusion: In most cases, the ‘Cancer Home-Life Intervention’ was delivered through only one home visit and one follow-up 
telephone contact, which not was effective in maintaining or improving participants’ everyday activities and health-related quality of 
life. Future research should pay even more attention to intervention development and feasibility testing.
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What is already known about the topic?
•• Many people with advanced cancer want to stay at home for as long as possible.
•• Research shows that people with advanced cancer have difficulties performing and participating in everyday activities at 
home, and this may reduce their health-related quality of life (HRQoL).
•• Only two pilot studies and an underpowered randomised controlled trial (RCT) have so far investigated the efficacy of 
occupational therapy–based (OT-based) interventions that support people with advanced cancer in performing and 
participating in everyday activities.
What this paper adds?
•• It was feasible to conduct a full-scale RCT for people with advanced cancer.
•• The majority of the participants wanted and needed OT-based interventions that supported their everyday activities at 
home.
•• We found no effect of the ‘Cancer Home-Life Intervention’ on activities of daily living (ADL) performance, difficulty 
performing prioritised everyday activities, autonomy and participation, or HRQoL.
Implications for practice, theory or policy
•• This is the first full-scale, sufficiently powered RCT to investigate the efficacy of an OT-based intervention in people with 
advanced cancer.
•• Future RCTs evaluating efficacy of OT-based interventions in this population require even more attention to interven-
tion development and feasibility testing.
•• Future studies need to consider if patients selected for their studies should have more severe functional limitations than 
was the case in our study and if the intervention is relevant to patients.
Introduction
More people live longer with advanced cancer,1,2 and 
many of them want to stay at home for as long as possi-
ble.3,4 Research shows that most people with advanced 
cancer have difficulties performing and participating in 
everyday activities,5–10 which can affect their ability to 
stay at home and in turn reduce their health-related quality 
of life (HRQoL).11 Everyday activities refer to everything 
people do in daily life, like self-care and housework (activ-
ities of daily living (ADL)), work and leisure,12 with ADL 
being essential for maintaining independent living.13
Several qualitative studies emphasise that maintaining 
everyday activities and independence is an important pri-
ority for people with advanced cancer.14–18 However, 
Cheville et al.5 showed that more than 43% of women with 
metastatic breast cancer (N = 163) had difficulties perform-
ing ADL. Rainbird et al.10 revealed that 10%–30% of peo-
ple with advanced cancer (N = 246) needed help with 
housework and preparing meals, 31% feared losing their 
independence and 40% were frustrated by being unable to 
participate in the activities they used to do previously. This 
resonates with a study by Johnsen et al.6 where 29% 
(N = 901) of people with advanced cancer did not receive 
the help they need concerning ADL. Similarly, Wæhrens 
et al.8 found that among people with advanced cancer, 53% 
(N = 136) had an observed ADL performance level requir-
ing assistance to perform ADL and prioritised everyday 
activity problems mainly within mobility and domestic 
life.9 Thus, to support people with advanced cancer in liv-
ing their lives as fully as possible, palliative care must also 
focus on enabling the patients’ everyday activities.
A growing body of rehabilitation research on people 
with advanced cancer demonstrates effects on function and 
independence.19–26 These studies are largely exercise-
based interventions.22–26 Occupational therapy–based 
(OT-based) interventions bring a different approach to 
existing palliative care interventions by intervening more 
directly on the target population’s everyday activity prob-
lems.27 A key principle underpinning most OT-based inter-
ventions is a person-centred approach where the 
interventions are tailored to patient’s priorities,27 which is 
in accordance with palliative care principles.28 To our 
knowledge, only two pilot randomised controlled trials 
(RCT)29,30 and one underpowered full-scale RCT31 have 
investigated OT-based interventions in people with 
advanced cancer. All three studies29–31 included adaptive 
interventions delivered by OTs, that is, interventions that 
include intrinsic changes, like change of habits and behav-
iour, and/or extrinsic changes, for example, provision of 
assistive technology and home modification.32 Overall, the 
studies29–31 showed that delivering an adaptive interven-
tion focused on everyday activities for people with 
advanced cancer was feasible, although two of the studies 
had significant problems with recruitment and attrition.30,31 
Due to the limited evidence of OT-based interventions in 
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people with advanced cancer, we developed the ‘Cancer 
Home-Life Intervention’.12
This study evaluates the efficacy of the ‘Cancer Home-
Life Intervention’ and usual care compared with usual care 
alone in people with advanced cancer living at home in 
relation to ADL performance, difficulty performing priori-
tised everyday activities, autonomy and participation, and 
HRQoL.
Methods
Trial design
This parallel group, superiority RCT with balanced ran-
domisation (1:1) consecutively recruited participants from 
oncology units at Aarhus University Hospital (AUH), 
Denmark, and Odense University Hospital (OUH), 
Denmark, from February 2015 to October 2016. The Ethics 
Committee decided that no approval was required for this 
study (S-20122000-96). The study was approved by the 
Danish Data Protection Agency (FN 215-57-0008) and reg-
istered at ClinicalTrials.gov (NCT02356627). A previous 
article describes the details of the protocol.12
Participants
Eligible participants were home-living adults (⩾18 years) 
diagnosed with advanced cancer by their responsible 
oncologist, had a World Health Organization (WHO) 
Performance Status (PS) 1–2 (see Appendix 1)33 and lived 
at home or in sheltered living within a maximum radius of 
60 km from AUH or on the island of Funen. Ineligible par-
ticipants were living in a nursing home or hospice, were 
cognitively impaired or had insufficient Danish language 
skills. The enrolled participants provided written informed 
consent.
Intervention and control
The ‘Cancer Home-Life Intervention’ is a tailored, 
OT-based, adaptive programme for people with advanced 
cancer delivered by OTs. It aims to enable people to per-
form and participate in the everyday activities at home that 
they prioritise but have difficulties performing (e.g. ADL, 
leisure, social activities) through application of one or 
more of the six components (Table 1), with component 1 
being mandatory. The rationale of the intervention is to 
compensate for their functional limitations by providing 
the participant with adaptive strategies that have the poten-
tial to give people more energy to perform and participate 
in the everyday activities they prioritise. The adaptive 
components include intrinsic and extrinsic changes, like 
supporting them to prioritise time and to divide activities 
into smaller parts, teaching them strategies to use their 
body in a more efficient and safe manner, and providing 
assistive technology and home modifications. All compo-
nents are delivered through instruction in and practice of 
the selected strategies. Each participant is offered 1–3 
face-to-face home visits lasting max 120 min and 1–3 tel-
ephone contacts after the first intervention visit to rein-
force intervention strategy use and resolve any emerging 
problems. The tailoring (which components and the num-
ber of components and home visits) is based on the partici-
pant’s type of activity problems. For details, see the 
protocol and Table 1.12
Usual care comprised home-care, palliative care and/or 
rehabilitation that sometimes also involved OT as pro-
vided by the participants’ home municipality.
Procedures
Six intervention occupational therapists (I-OTs) performed 
the intervention. The I-OTs participated in a one-day 
workshop where they trained in performing the interven-
tion with time to discuss the different parts of the interven-
tion with the developers in order to standardise the delivery 
of the intervention. The I-OTs participated in three meet-
ings during the study period to enhance the fidelity of the 
intervention. During delivery, the I-OTs monitored their 
fidelity to the intervention manual by reporting which 
components they provided to each participant.12 Eight 
trained data-collection occupational therapists (D-OTs) 
collected the data from February 2015 to December 2016. 
They collected baseline (T1) and 12-week (T3) data in the 
participants’ homes. Six-week (T2) data were collected 
using a postal questionnaire and telephone interview.
Outcome measures
ADL performance. The Assessment of Motor and Process 
Skills (AMPS) is an observation-based instrument measur-
ing the observed quality of ADL task performance. It has 
two domains: ADL motor ability and ADL process ability. 
Higher positive measures represent better ADL perfor-
mance. Measures of ⩾0.3 logits on both indicate a clini-
cally relevant change. ADL motor ability measures above 
2.0 logits and ADL process ability measures above 1.0 
logits represent competent ADL performance (no physical 
effort, efficient, safe and independent). The AMPS has 
demonstrated sound psychometric properties in terms of 
validity and reliability among people with cancer34,35 and 
sensitivity to change in other diagnostic groups.13
Difficulties performing the participants’ prioritised everyday 
activities. The Individually Prioritised Problem Assess-
ment (IPPA) is a generic, structured interview–based 
instrument that is used to identify participants’ prioritised 
everyday activities and the ease/difficulty participants 
encounter when performing them.36 The participants pri-
oritise up to seven activity problems and rate the 
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importance and difficulty of these problems. In this study, 
prioritised activity problems were limited to those in the 
home environment. IPPA scores range from 1 to 25, with a 
higher score indicating a greater degree of difficulty per-
forming prioritised everyday activities. The IPPA has been 
found to be a responsive and valid instrument in elderly 
people.37,38
Autonomy and participation. The Danish version (IPA-DK) 
of the Impact on Participation and Autonomy Questionnaire 
(IPAQ) is a generic questionnaire used to identify person-
perceived participation restrictions. It has five domains.39 
We used autonomy indoors, family roles and social relations 
subscales with scores ranging from 0–4, with 0 being no 
participation restrictions and 4 being perceived severe par-
ticipation restrictions. The scores were dichotomised into no 
perceived restrictions (score 0 and 1) and perceived restric-
tions (scores 2, 3 and 4). The IPA-DK and IPAQ have 
demonstrated acceptable psychometric properties regarding 
validity, reliability and sensitivity.40–43
HRQoL. The European Organisation for Research and 
Treatment of Cancer Quality-of-Life Questionnaire Core 
30 (EORTC QLQ C-30) is a cancer-specific question-
naire assessing HRQoL and consists of 15 scales.44 We 
used the global health status/Quality of Life scale as an 
overall measure of HRQoL, with scores ranging from 0 
to 100, where higher scores indicate better HRQoL.44 The 
EORTC QLQ C-30 has been found to be a responsive, 
valid and reliable instrument among people with advanced 
cancer.45,46
Primary outcome
•• Change in ADL motor ability from T1–T3 meas-
ured with the AMPS.13
Table 1. Description of the ‘Cancer Home-Life Intervention’.
Intervention features Intensity and content
Setting Participant’s home
Format Individual
Intervention provider Occupational therapist
Number of home visits 1–3
Intervention period ⩽3 weeks
Time per visit 60–120 min
Telephone follow-up 1–3
Mandatory component
Component 1 Initial interview
Identify prioritised everyday activity problems in the home environment. The I-OT and the participant 
schedule an intervention plan together.They select which of the five optional components that should 
be included, tailoring the intervention to the participant’s needs with their prioritised everyday 
activities.
Optional components
Component 2 Prioritisation of resources, energy and activities
Instructing participant in energy conservation techniques, talking about time to rest during the day and 
delegating activities to family members or other people, for instance, so that participants can perform 
and participate in their prioritised everyday activities.
Component 3 Adaptation of activities
Instructing participant in how to perform prioritised everyday activities in alternative ways according 
to symptom management, for example, by working in a seated position instead of standing, splitting 
tasks into actions, reordering actions and asking for assistance.
Component 4 Adaptation of posture and seating positioning
Instructing participants and practising seated positioning and ergonomics when performing their 
prioritised everyday activities, for example, lifting techniques, how to obtain a good seating/standing 
position during activity and how to obtain a good resting position in bed or other places.
Component 5 Provision of assistive technology
Selecting assistive devices for participants and instructing and practicing in using them when performing 
prioritised everyday activities, for example, mobility devices, devices for gardening, devices for handling 
cold objects.
Component 6 Modification of the physical home environment
Providing home safety and home modification, for example, rearranging furniture or setting up 
handrails, and ensuring home safety.
I-OT: intervention occupational therapist.
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Secondary outcomes
•• Change in ADL process ability from T1–T3 meas-
ured with the AMPS;13
•• Change in difficulties performing prioritised every-
day activities from T1–T2 and from T1–T3 assessed 
with the IPPA;36
•• Probability of no perceived participation restric-
tions within the domains autonomy indoors, family 
role and social relations at T2 and T3 assessed by 
the IPA-DK;39
•• Change in HRQoL from T1–T2 and from T1–T3 
assessed by the EORTC QLQ C-30.44
Sample size
To identify a clinically relevant between-group change of 
0.3 logits on the ADL motor ability, we needed to recruit 
272 participants with an expected attrition of 32% (N = 184 
would provide 80% power). Alpha was 5% and the stand-
ard deviation (SD) 0.727.12
Randomisation and masking
After T1, the D-OTs randomised the participants to one of 
the two groups using online computer-generated randomi-
sation with a fixed block size prepared by the Odense 
Patient Data Explorative Network that had no other study 
involvement.
Analyses were performed masked for the group alloca-
tion. The D-OTs were masked when collecting the out-
come measures.
Analyses
Descriptive data are presented with mean values and SD, 
median and interquartile range (IQR), or number and per-
cent. For quantitative outcomes (AMPS, IPPA and EORTC 
QLQ C-30), change in the intervention group was compared 
with change in the control group47 using multiple linear 
regression analyses. Analyses were adjusted for hospital.
Logistic regression analysis was performed comparing 
the odds ratio (OR) of not having perceived participation 
restrictions within the three IPA-DK domains. Between-
group change and the OR were presented with 95% confi-
dence intervals (CI).
Primary analyses were performed as complete case 
analysis, excluding participants with missing outcome 
measure values and with invalid AMPS data. Data were 
analysed according to original group allocation; and two 
sensitivity analyses were conducted to examine the robust-
ness of the primary analyses:
1. Linear regression analysis adjusted for unbalanced 
variables at T1 between the groups.12
2. Mixed linear models to investigate change over 
time and between-group differences for quantita-
tive outcomes.
p values ⩽0.05 were considered statistically signifi-
cant. Analyses were performed using STATA 14.
Results
Participants
Between 16 January 2015 and 28 September 2016, 522 
people were invited to participate (Figure 1). Measures 
were completed at T1 by 242 participants who were ran-
domised to intervention (n = 121) or control (n = 121). No 
significant differences for age (p = 0.29), gender (p = 0.55), 
WHO PS (p = 0.65) and primary cancer type (p = 0.24) 
were found between participants and those who declined 
participation.
Attrition was almost similar (intervention: 8.3% (T2) 
and 9.9% (T3)) versus control: 7.4% (T2) and 12.4% (T3)) 
with death and illness being the main causes. T3 (AMPS: 
n = 1 invalid) was completed by 191 participants (Figure 
1). The number of people included was sufficient to reach 
the calculated sample size (N = 184).
The mean age for the study population was 67.91, 
slightly more women than men participated (124 (51.2%)), 
and the majority of the participants were living with a part-
ner (167 (68.9%)). The most common primary cancer 
types were gastrointestinal (74 (30.6%)), lung (48 (19.8%)) 
and breast (37 (15.3%)). The mean ADL motor ability was 
1.13 logits, namely, far below the competence cut-off 
(<2.0 logits), indicating safety risk and/or need for assis-
tance during ADL performance. The mean ADL process 
ability was 0.84 logits, which is just below the competence 
cut-off (<1.0 logits). Participants encountered difficulties 
performing their prioritised everyday activities (mean 
score 14.26 on 1–25 scale) and had reduced HRQoL (mean 
score 58.51 on 0–100 scale). They reported almost no per-
ceived participation restrictions within the three subdo-
mains of the IPA-DK (Table 2).
We found the two groups comparable at baseline, but 
did see slightly more women in the control group. We 
therefore adjusted for gender in the sensitivity analyses.
Delivered interventions
Eight participants declined the intervention (6.61%). The 
remainder of the intervention group received the manda-
tory component 1 (113 (93.4%)). The median number of 
delivered components was three. A total of 36 partici-
pants (29.8%) received more than one home visit, and 62 
participants (51.2%) received at least one follow-up tel-
ephone contact (Table 3). Agreement between the D-OTs’ 
estimate of group allocation and the actual allocation was 
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66.2% (k = 0.32 (95% CI: 0.21–0.44)), indicating weak 
agreement. Five participants (4.1%) in the control group 
received some element of OT from their local municipal-
ity during T1–T2 and two participants (1.7%) from 
T2–T3.
The primary outcome
ADL motor ability decreased in both groups during T1–T3 
(Figure 2(a)). The within-group change was small (inter-
vention group: –0.14 logits (95% CI: –0.27 to 0.00)) (con-
trol group: –0.10 logits (95 CI: –0.24 to 0.05); Table 4) 
with the change in the intervention group being borderline 
significant. We observed no statistically significant effect 
of the ‘Cancer Home-Life Intervention’ on the primary 
outcome from T1–T3 (between-group mean change in 
ADL motor ability: –0.04 logits (95% CI: –0.23 to 0.15); 
p = 0.69; Table 4). Sensitivity analyses did not change the 
results.
Secondary outcomes
Both groups’ ADL process ability decreased during T1–
T3 (Figure 2(b)). The two groups experienced statisti-
cally less difficulty performing their prioritised everyday 
activities over time (Table 4). Small within-group change 
was found concerning HRQoL, decreasing during T1–T2 
and increasing during the last follow-up (Figure 2(d)). 
The probability of no perceived participation restrictions 
was high for both groups at both follow-ups. No statisti-
cally significant between-group differences were found 
(Table 4). Sensitivity analyses confirmed the results of no 
intervention effect.
Discussion
This RCT evaluated the efficacy of the ‘Cancer Home-Life 
Intervention’ compared with usual care alone in people 
with advanced cancer living at home. We found no 
Figure 1. Flow chart
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Table 2. Participants’ baseline characteristics (N = 242).
Study population (N = 242) Intervention group (n = 121) Control group (n = 121)
Age (years), mean (SD) 67.91 (9.00) 68.67 (8.64) 67.16 (9.32)
Women, n (%) 124 (51.2) 54 (44.6) 70 (57.9)
Hospital, n (%)
 AUH 222 (91.7) 111 (91.7) 111 (91.7)
 OUH 20 (8.3) 10 (8.3) 10 (8.3)
Living alone, n (%) 74 (30.7) 33 (27.5) 41 (33.9)
 Missing, n (%) 1 (0.4) 1 (0.8) 0 (0.00)
Type of residence, n (%)
 House 168 (69.7) 85 (70.8) 83 (68.6)
 Apartment 57 (23.7) 25 (20.8) 32 (26.5)
 Other 16 (6.6) 10 (8.3) 6 (5.0)
 Missing, n (%) 1 (0.4) 1 (0.8) 0 (0.00)
Education, n (%)
 ⩽10 years 64 (26.7) 31 (25.8) 33 (27.5)
 11–12 years 63 (26.3) 37 (30.8) 26 (21.7)
 >13 years 113 (47.1) 52 (43.3) 61 (50.8)
 Missing, n (%) 2 (0.8) 1 (0.8) 1 (0.8)
Comorbidities, n (%)
 0 52 (21.5) 25 (21.6) 27 (22.5)
 1–3 161 (66.5) 79 (68.1) 82 (68.3)
 >3 23 (9.5) 12 (10.3) 11 (9.2)
 Missing, n (%) 6 (2.5) 5 (4.1) 1 (0.8)
Primary tumour site, n (%)
 Gastrointestinal 74 (30.6) 44 (36.4) 30 (24.8)
 Lung 48 (19.8) 22 (18.2) 26 (21.5)
 Breast 37 (15.3) 16 (13.2) 21 (17.4)
 Prostate 30 (12.4) 16 (13.2) 14 (11.6)
 Head and neck 17 (7.0) 10 (8.3) 7 (5.8)
 Bladder 15 (6.2) 6 (5.0) 9 (7.4)
 Gynaecological 14 (5.8) 2 (1.2) 12 (9.9)
 Other 6 (2.5) 5 (4.1) 1 (0.8)
 Missing, n (%) 1 (0.4) 0 (0.0) 1 (0.8)
WHO Performance Status, n (%)
 1 171 (71.0) 81 (67.5) 90 (74.4)
 2 70 (29.1) 39 (32.5) 31 (25.6)
 Missing, n (%) 1 (0.4) 1 (0.8) 0 (0.0)
ADL motor ability (AMPS), mean (SD)a 1.13 (0.59) 1.12 (0.58) 1.14 (0.59)
 Below competence cut-off, n (%)b 230 (95.4) 117 (97.5) 113 (93.4)
 Missing, n (%) 1 (0.4) 1 (0.8) 0 (0.0)
ADL process ability (AMPS), mean 
(SD)a
0.84 (0.39) 0.85 (0.39) 0.84 (0.38)
 Below competence cut-off, n (%)b 142 (58.9) 71 (59.2) 71 (58.7)
 Missing, n (%) 1 (0.4) 1 (0.8) 0 (0.0)
IPPA mean score (SD)c,d 14.26 (4.06) 14.16 (3.65) 14.35 (4.45)
 Missing, n (%) 3 (1.2) 0 (0.0) 3 (3.3)
 Number of activity problems, n (%)  
  0 64 (26.6) 33 (27.5) 31 (25.6)
  1–3 76 (31.5) 35 (29.2) 41 (33.9)
  >3 101 (41.9) 52 (43.3) 49 (40.5)
  Missing, n (%) 1 (0.4) 1 (0.8) 0 (0.0)
HRQoL (QLQ-C30), mean (SD)e,f 58.51 (21.98) 57.64 (22.7) 59.38 (21.4)
 Missing, n (%) 2 (0.8) 1 (0.8) 1 (0.8)
 (Continued)
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statistically significant effect of the OT-based intervention 
(Table 4).
Overall, our trial demonstrates high internal validity 
with limited and equal attrition between the groups, 
blinded assessors, sufficient statistical power and success-
fully performed randomisation. Below we discuss several 
aspects that need to be considered before one hastily con-
cludes that OT-based interventions has no effect in people 
with advanced cancer.
Intervention intensity
The delivered ‘Cancer Home-Life Intervention’ was tai-
lored and adjusted to the participants. In this study, this 
resulted in the intervention mainly encompassing three 
components, most of which were used during one home 
visit (median minutes = 105) and one telephone contact 
over a 3-week time span (Table 3). One explanation for 
why the ‘Cancer Home-Life Intervention’ showed no 
effect in this study may be that the intensity of the inter-
vention was too low. An important question in this respect 
is what is a minimum of OT-based intervention required to 
instil change. To our knowledge, no clear cut-off of the 
minimum intensity required to instil change exists.48 A 
systematic review49 found short-term effects on ADL and 
prioritised everyday activities of low intensity OT-based 
interventions in older people delivered over 2.5–6 months 
with a mean intensity varying from 0.8 to 3.4 intervention 
sessions per month.49 The literature on behavioural change 
would argue that one home visit and one telephone contact 
is not enough to change strategies and achieve change, as 
this requires more therapeutic support over longer periods 
Study population (N = 242) Intervention group (n = 121) Control group (n = 121)
Autonomy indoor (IPA-DK), median 
(IQR)g
0 (0–1) 0 (0–1) 0 (0–1)
 Missing, n (%) 2 (0.8) 1 (0.8) 1 (0.8)
Family role (IPA-DK), median (IQR)g 1 (0–2) 1 (0–2) 1 (0–2)
 Missing, n (%) 3 (1.2) 1 (0.8) 2 (1.7)
Social relations (IPA-DK), median 
(IQR)g
0 (0–1) 0 (0–1) 0 (0–0)
 Missing, n (%) 5 (2.1) 3 (2.5) 2 (1.7)
SD: standard deviation; AUH: Aarhus University Hospital; OUH: Odense University Hospital; WHO: World Health Organization; ADL: activities of 
daily living; AMPS: Assessment of Motor and Process Skills; IPPA: Individually Prioritised Problem Assessment; HRQoL: health-related quality of life; 
QLQ-C30: European Organisation for Research and Treatment of Cancer Quality of life C-30; IPA-DK: The Danish Version (IPA-DK) of the Impact 
on Participation and Autonomy Questionnaire (IPAQ); IQR: interquartile range.
aHigher positive measures represent a greater degree of ADL ability.
bBelow competent cut-off on the ADL motor ability (<2.0 logits) and the ADL process ability (<1.0 logits).
cThe IPPA score ranges from 1 to 25, with higher scores indicating a greater degree of difficulty performing prioritised everyday activities.
dOnly includes participants with at least one prioritised activity problem (intervention group: n = 87 and control group: n = 90).
eThe global health status/quality of life scale from the EORTC QLQ C-30 is used to assess HRQoL.
fThe HRQoL ranges from 0 to 100, with higher scores indicating a greater degree of HRQoL.
gThe IPA-DK ranges from 0 to 4, with 0 being no perceived participation restrictions and 4 being severe perceived participation restrictions.
Table 2. (Continued)
Table 3. Components from the ‘Cancer Home-Life 
Intervention’ delivered to the participants in the intervention 
group (N = 121)a and total number of home visits, telephone 
follow-up contacts and time.
The ‘Cancer Home-Life Intervention’  
Components given by the intervention occupational therapist, 
n (%)
1. Interview 113 (93.4)
2. Prioritise resources, energy and 
activities
73 (60.3)
3. Adaptation of activities 70 (57.9)
4. Adaptation of posture and seated 
positioning
37 (30.6)
5. Assistive technology 65 (53.7)
6. Modification of the physical home 
environment
11 (9.1)
Number of components per participant, median (IQR)
 Number 3 (2–4)
Home visits, n (%)
 First home visit 113 (93.4)
 Second home visit 32 (26.4)
 Third home visit 4 (3.3)
Time, median minutes (IQR)
 First home visit 105 (90–120)
 Second home visit 45 (30–75)
 Third home visit 45 (22.5–75)
Telephone follow-up, n (%)
 No follow-up telephone contact 13 (10.7)
 First follow-up telephone contact 62 (51.2)
 Second follow-up telephone contact 39 (32.2)
 Third follow-up telephone contact 7 (5.8)
IQR: interquartile range.
aEight participants did not want to receive the intervention.
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of time.50 However, a telephone-delivered problem- 
solving OT-based intervention by Hegel et al.29 lasted on 
average 106 min, and they found effect on function, 
HRQoL and emotional state. This amount of time almost 
equals the time used in our intervention. When we designed 
the trial, we decided that 1–3 visit would be enough – 
partly based on the trial by Hegel et al.29 Moreover, we had 
expected that most participants would receive more than 
one visit. However, based on our results and the knowl-
edge of behaviour change theory,50 one may consider if we 
should have delivered the intervention over a longer period 
of time and increased the intensity.
Feasibility
We did not conduct a full feasibility study before the 
trial as advocated by the Medical Research Council,51 
since our cross-sectional study gave us knowledge 
about relevant outcomes, and we had sufficient infor-
mation for estimating sample size, recruitment and so 
on.12 Furthermore, we had explored the acceptability 
and usefulness of the intervention in four people with 
advanced cancer, which showed that they definitely 
would value such an intervention.12 Still, a full feasibil-
ity study could have given us important information 
about required intervention intensity and intervention 
relevance.
Outcomes
Many people with advanced cancer face serious difficul-
ties with ADL,5,6,8,9 which motivated our choice of ADL as 
the primary trial outcome.8 However, they also experience 
difficulties in other areas at home, such as leisure and 
Figure 2. Change over time and between-group differences. ADL=Activities of Daily Living; AMPS=Assessment of Motor and Process Skills; 
IPPA=Individually Prioritised Problem Assessment; HRQoL=Health-related Quality of Life; QLQ-C30=European Organisation for Research and 
Treatment of Cancer Quality of Life Questionnaire C-30.
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Table 4. Mean change in primary outcome and secondary outcomes from baseline (T1) to six- (T2) and 12-week follow-up (T3) 
and odds ratio for no perceived participation restrictions; complete case analysis.
Outcomes n Intervention group n Control group Between-group mean 
change (95% CI)
p value
 Mean change Mean change  
AMPS
ADL motor ability T1–T3a,b,c,d 97 −0.14 (–0.27 to 0.00) 94 −0.10 (–0.24 to 0.05) −0.04 (–0.23 to 0.15) 0.69
ADL process ability T1–T3a,b,c,d 97 −0.10 (–0.20 to –0.01) 94 −0.04 (–0.14 to 0.06) −0.06 (–0.20 to 0.07) 0.37
IPPA
IPPA score T1–T2c,d,e 67 −1.27 (–2.01 to –0.53) 65 −1.16 (–1.91 to –0.41) −0.11 (–1.17 to 0.95) 0.83
IPPA score T1–T3c,d,e 62 −1.38 (–2.35 to –0.40) 63 −1.03 (–2.00 to –0.05) −0.35 (–1.71 to 1.01) 0.61
EORTC QLQ C-30
HRQoL T1–T2c,d,f,g 94 −1.40 (–5.49 to 2.68) 93 −1.19 (–5.39 to 3.01) −0.21 (–5.97 to 5.54) 0.94
HRQoL T1–T3c,d,f,g 93 1.50 (–2.97 to 5.97) 90 3.11 (–1.52 to 7.74) −1.61 (–7.95 to 4.73) 0.62
Outcomes n Intervention group n Control group Odds ratio for no 
perceived participation 
restrictions (95% CI)
p value
 Oddsi Oddsj  
IPA-DKh
Autonomy Indoor T2 95 7.64 (4.07 to 14.32) 91 6.00 (3.36 to 10.79) 1.27 (0.54 to 3.02)j,k 0.59
Autonomy Indoor T3 89 8.89 (4.46 to 17.71) 87 8.67 (4.35 to 17.28) 1.03 (0.39 to 2.75)j,k 0.95
Family role T2 95 1.21 (0.81 to 1.81) 91 1.39 (0.92 to 2.12) 0.83 (0.46 to 1.50)j,k 0.54
Family role T3 89 1.70 (1.10 to 2.61) 87 1.56 (1.01 to 2.40) 1.08 (0.59 to 1.99)j,k 0.81
Social relations T2 95 18.00 (7.31 to 44.30) 89 13.83 (6.04 to 31.68) 1.22 (0.35 to 4.21)j,k 0.75
Social relations T3 89 11.71 (5.41 to 25.34) 87 13.50 (5.89 to 30.94) 0.86 (0.28 to 2.69)j,k 0.80
AMPS: Assessment of Motor and Process Skills; ADL: activities of daily living; IPPA: Individually Prioritised Problem Assessment; IPA-DK: The Danish 
Version (IPA-DK) of the Impact on Participation and Autonomy Questionnaire (IPAQ); EORTC QLQ-C30: European Organisation for Research and 
Treatment of Cancer Quality of Life Questionnaire C-30; HRQoL: Health-related Quality of Life.
aHigher positive measures represent a greater degree of ADL ability.
bExponential transformation of the difference between groups did not change the results.
cMultiple linear regression adjusted for hospital. The estimates are shown in the table.
dMultiple linear regression adding gender in the model did not change the results and are therefore not shown in table.
eThe IPPA score ranges from 1 to 25, with higher scores indicating a greater degree of difficulty performing prioritised everyday activities.
fThe global health status/quality of life scale from the EORTC QLQ C-30 is used to assess HRQoL.
gThe HRQoL ranges from 0 to 100, with higher scores indicating a greater degree of HRQoL.
hThe IPA-DK were dichotomised into ‘no perceived participation restrictions’ and ‘perceived participation restrictions’.
iOdds for no perceived participation restrictions.
jLogistic regression adjusted for hospital. The estimates are shown in the table.
kLogistic regression adding gender in the model did not change the results and are therefore not shown in table.
creative activities,7 which our intervention was also 
designed to solve.
Selecting outcome measures that capture the essence of 
an intervention is challenging, especially in people with 
advanced cancer with complex and diverse needs.6 
Outcome measures in palliative care need to be psycho-
metrically robust and sensitive to capture change over 
time.52 Sensitivity to change is particularly important when 
evaluating intervention effect. We selected the AMPS as 
an ADL measure because it is highly sensitive13 and more 
sensitive in oncology patients than other tools.53 However, 
the ‘Cancer Home-Life Intervention’ targeted participants’ 
prioritised everyday activity problems which do not always 
include ADL. This could have affected the causal connec-
tion between the ‘Cancer Home-Life Intervention’ and the 
AMPS, which may have been too narrow in scope.
Recruitment
Recruiting the most relevant study population is another 
challenge. We may have included individuals without the 
most urgent need for the intervention since 26.6% of the 
participants reported no activity problems (Table 2). We 
cannot rule out that this may have biased the results 
towards the null value as these people probably received a 
smaller amount of interventions. Over two-thirds of the 
participants had a WHO PS1, meaning that we mostly 
recruited better functioning people with advanced cancer. 
People with WHO PS1 still have difficulties performing 
physically strenuous activities but may have less difficul-
ties performing ADL. However, their ADL ability meas-
ured with the AMPS clearly indicated need of assistance to 
live in the community. Nevertheless, this issue raises the 
754 Palliative Medicine 32(4)
question whether we have identified the most appropriate 
participants for an OT-based intervention since so many 
had no prioritised activity problem. A solution could have 
been to use self-reported activity problems as an inclusion 
criterion.
What this study adds
This study is the first full-scale, adequately powered 
RCT investigating the efficacy of an OT-based interven-
tion in people with advanced cancer.54,55 Our study dem-
onstrates that it is feasible to conduct a full-scale RCT in 
this vulnerable group of people and that the majority of 
them want and need OT-based interventions that support 
their everyday activities at home. This underlines that 
even though our RCT produced no evidence supporting 
the benefits of the present OT-based intervention, 
research and clinical practice in palliative care still need 
to focus on how to enable everyday activities in people 
with advanced cancer, helping them to live their lives as 
fully as possible.
Conclusion
The ‘Cancer Home-Life Intervention’, delivered mostly 
through a single home visit and a single follow-up tele-
phone contact, was not effective in maintaining or improv-
ing participants’ everyday activities and HRQoL. Future 
studies should pay even more attention to intervention 
development, minimal intervention ‘dose’ believed to 
make a change and feasibility testing.
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Appendix 1. Description of the World Health Organization 
performance status.
Grade Explanation of activity
0 Fully active, able to carry on all pre-disease 
performance without restriction
1 Restricted in physically strenuous activity but ambulatory 
and able to carry out work of a light or sedentary 
nature, for example, light housework, office work
2 Ambulatory and capable of all self-care but unable 
to carry out any work activities. Up and about more 
than 50% of waking hours
3 Capable of only limited self-care, confined to bed or 
chair more than 50% of waking hours
4 Completely disabled. Cannot carry on any self-care. 
Totally confined to bed or chair
5 Dead
